发明授权
- 专利标题： Pyrrolopyrimidines and pyrrolopyridines
- 专利标题（中）： 吡咯并嘧啶和吡咯并吡啶类
-
申请号： US12351438申请日： 2009-01-09
-
公开(公告)号： US08314112B2公开(公告)日： 2012-11-20
- 发明人: Catherine Leblanc , Robert Alexander Pulz , Nikolaus Johannes Stiefl
- 申请人： Catherine Leblanc , Robert Alexander Pulz , Nikolaus Johannes Stiefl
- 申请人地址： CH Basel
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： CH Basel
- 代理商 John B. Alexander
- 优先权： EP08150182 20080111
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61K31/519 ; C07D471/04 ; A61K31/437
摘要：
Compounds of formula I in free or salt or solvate form, wherein X, T1, T3 and T4 have the meanings as indicated in the specification, are useful for treating diseases mediated by the ALK-5 and/or ALK-4 receptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
公开/授权文献
- US20090181941A1 Pyrrolopyrimidines and Pyrrolopyridines 公开/授权日：2009-07-16
信息查询
